Significantly Elevated CA 19-9 after COVID-19 Vaccination and Literature Review of Non-Cancerous Cases with CA 19-9> 1000 U/mL

J Ciesielka, K Jakimów, N Tekiela, L Peisert… - Journal of Clinical …, 2024 - mdpi.com
Background: CA 19-9 is a commonly assessed tumor marker, considered characteristic of
pancreatic ductal adenocarcinoma (PDAC) and biliary tract cancers; however, the positive …

[HTML][HTML] A case of Choledocholithiasis and obstructive jaundice with a very high serum carbohydrate antigen 19-9 (CA 19-9) level: a case report and review of …

M Ghallab, H Abosheaishaa, I Gupta, S Abdelmoteleb… - Cureus, 2022 - ncbi.nlm.nih.gov
Abstract Carbohydrate antigen 19-9 (CA 19-9) is a tumor marker used clinically to support
the diagnosis and recurrence of pancreatic adenocarcinoma. CA 19-9 levels may be found …

[HTML][HTML] 血清CA199 对继发性急性胆管炎的早期预判价值

居晓丹, 李鹏飞, 张鹏斌 - 世界华人消化杂志, 2017 - wjgnet.com
血清CA199对继发性急性胆管炎的早期预判价值 主页 简体中文 English 简体中文 登录 BPG
Management System F6Publishing-Submit a Manuscript F6Publishing-世界华人消化杂志在线 …

[HTML][HTML] Pulmonary sequestration associated with a synchronous elevation of carbohydrate antigen 50 and 19-9: a case report

S Fu, H Wang - Annals of Translational Medicine, 2018 - ncbi.nlm.nih.gov
This report describes a 37-year-old woman who experienced elevated serum carbohydrate
antigen 19-9 (CA19-9) and carbohydrate antigen 50 (CA50). Intralobar pulmonary …

An extremely increased CA19-9 level due to common bile duct stone: a case report

X Wang, X Qi, H Li, X Shao, X Guo - AME Medical Journal, 2017 - amj.amegroups.org
Serum carbohydrate antigen 19-9 (CA19-9), a common tumor marker, is frequently
increased in bile duct malignancy. We reported a case with an extremely increased CA19-9 …

[HTML][HTML] 应用改良的组织块酶消化法体外培养人大肠癌原代细胞

梁剑华, 张雯, 郭强, 唐慧 - 世界华人消化杂志, 2016 - wjgnet.com
应用改良的组织块酶消化法体外培养人大肠癌原代细胞 主页 简体中文 English 简体中文 登录
BPG Management System F6Publishing-Submit a Manuscript F6Publishing-世界华人消化杂志 …